Proteomics in Pancreatic Cancer Research

  • Geng R
  • Li Z
  • Li S
  • et al.
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely applied in clinical applications, especially in pancreatic cancer research. In this paper, we attempt to discuss the development of current proteomic technologies and the application of proteomics to the field of pancreatic cancer research. This will explore the potential perspective in revealing pathogenesis, making the diagnosis earlier and treatment.

Cite

CITATION STYLE

APA

Geng, R., Li, Z., Li, S., & Gao, J. (2011). Proteomics in Pancreatic Cancer Research. International Journal of Proteomics, 2011, 1–5. https://doi.org/10.1155/2011/365350

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free